|
TRIM59 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.78209999990698E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.42960000007564E-07 |
| Normal-vs-Stage2 |
5.001600E-01 |
| Normal-vs-Stage3 |
1.218410E-04 |
| Normal-vs-Stage4 |
1.60037999999973E-05 |
| Stage1-vs-Stage2 |
1.562100E-03 |
| Stage1-vs-Stage3 |
5.237600E-01 |
| Stage1-vs-Stage4 |
3.370200E-01 |
| Stage2-vs-Stage3 |
1.877500E-02 |
| Stage2-vs-Stage4 |
2.220600E-03 |
| Stage3-vs-Stage4 |
2.007400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.5460999997804E-07 |
| Normal-vs-AfricanAmerican |
8.395600E-03 |
| Normal-vs-Asian |
1.89896999999162E-05 |
| Caucasian-vs-AfricanAmerican |
5.790000E-01 |
| Caucasian-vs-Asian |
9.710400E-02 |
| AfricanAmerican-vs-Asian |
6.092200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.432910E-04 |
| Normal-vs-Female |
4.61199999968187E-07 |
| Male-vs-Female |
4.817000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.95400000519075E-08 |
| Normal-vs-Age(41-60Yrs) |
7.90890000000877E-05 |
| Normal-vs-Age(61-80Yrs) |
7.596700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.691920E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.907600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.965790E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.909200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.821000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.640800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.728000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.757800E-01 |
| Classical-VS-Follicular |
3.30799831971262E-11 |
| Classical-VS-Other |
1.962810E-01 |
| Classical-VS-Normal |
9.90859949645539E-10 |
| Tall-VS-Follicular |
2.42069999999428E-05 |
| Tall-VS-Other |
1.497020E-01 |
| Tall-VS-Normal |
1.732759999995E-05 |
| Follicular-VS-Other |
3.550200E-01 |
| Follicular-VS-Normal |
9.223400E-01 |
| Other-VS-Normal |
2.685800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.996890E-03 |
| Normal-vs-N1 |
2.13619999999137E-05 |
| N0-vs-N1 |
3.776400E-02 |
|
|
